Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A1RP
|
|||
| Former ID |
DNCL002601
|
|||
| Drug Name |
18F-fluorothymidine
|
|||
| Synonyms |
3'-Deoxy-3'-[18F]fluorothymidine; AC1L9P5W; SCHEMBL10017180; MOLI001306; NSC743144; NSC-743144; radiolabeled form of 3'-deoxy-3'-fluorothymidine (FLT) (NSC 140025)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 2 | [1] | |
| Company |
Merck
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H13FN2O4
|
|||
| Canonical SMILES |
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F
|
|||
| InChI |
1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/i11-1
|
|||
| InChIKey |
UXCAQJAQSWSNPQ-KXMUYVCJSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00572728) 3'-Deoxy-3'-18F Fluorothymidine PET/CT in Predicting Response To Chemotherapy Before Surgery in Patients With Locally Advanced Breast Cancer. U.S. National Institutesof Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.